In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Ingo Mellinghoff
Researchers Uncover Molecular Interactions in Common Form of Brain Cancer

A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
MSK Study Identifies Biomarker That May Help Predict Benefits of Immunotherapy

A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Sign for AACR scientific meeting featuring collage of images
Roundup
Highlights from MSK at the 2018 American Association for Cancer Research Meeting

Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.
Charles Sawyers presents at AACR 2026
AACR 2026 Research Roundup: The Latest Cancer Science Advances From MSK

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Illustration of immune cell opening as if on hinge and boxing glove coming out.
Q&A
New Approach Could Boost Immunotherapy for Breast Cancer

A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.
Physician-scientist Luc Morris
In the Lab
Clearing the Fog around Tumor Mutational Burden

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
Physician-scientist Omar Abdel-Wahab
In the Lab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Crowded hall with ASCO signage
Roundup
Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.